The L-type Ca2+ Channel as a Potential Mediator of Pathology During Alterations in Cellular Redox State

Soldatov, 1994, Genomic structure of human L-type Ca2+ channel, Genomics, 22, 77, 10.1006/geno.1994.1347 Dolphin, 2003, Beta subunits of voltage-gated calcium channels, J Bioenerg Biomembr, 35, 599, 10.1023/B:JOBB.0000008026.37790.5a Kobrinsky, 2005, Differential role of the alpha1C subunit tails in regulation of the Cav1.2 channel by membrane potential, beta subunits, and Ca2+ ions, J Biol Chem, 280, 12474, 10.1074/jbc.M412140200 Klugbauer, 1999, Molecular diversity of the calcium channel alpha2delta subunit, J Neurosci, 19, 684, 10.1523/JNEUROSCI.19-02-00684.1999 Bers, 2008, Calcium cycling and signaling in cardiac myocytes, Annu Rev Physiol, 70, 23, 10.1146/annurev.physiol.70.113006.100455 Tomida, 2003, NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation, EMBO J, 22, 3825, 10.1093/emboj/cdg381 Halliwell, 2004, Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?, Br J Pharmacol, 142, 231, 10.1038/sj.bjp.0705776 Thannickal, 2000, Reactive oxygen species in cell signaling, Am J Physiol, 279, L1005 Antunes, 2000, Estimation of H2O2 gradients across biomembranes, FEBS Lett, 475, 121, 10.1016/S0014-5793(00)01638-0 Hurd, 2005, Disulphide formation on mitochondrial protein thiols, Biochem Soc Trans, 33, 1390, 10.1042/BST20051390 Oshino, 1973, The role of H2O2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors, Arch Biochem Biophys, 154, 117, 10.1016/0003-9861(73)90040-4 Stone, 2006, Hydrogen peroxide: a signaling messenger, Antiox Redox Sig, 8, 243, 10.1089/ars.2006.8.243 Leto, 2006, Role of Nox family NADPH oxidases in host defense, Antiox Redox Sig, 8, 1549, 10.1089/ars.2006.8.1549 Behe, 2007, The function of the NADPH oxidase of phagocytes, and its relationship to other NOXs, Biochem Soc Trans, 35, 1100, 10.1042/BST0351100 Griendling, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494 Rajagopalan, 1996, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation Contribution to alterations of vasomotor tone, J Clin Invest, 97, 1916, 10.1172/JCI118623 Zafari, 1998, Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy, Hypertension, 32, 488, 10.1161/01.HYP.32.3.488 Byrne, 2003, Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy, Circ Res, 93, 802, 10.1161/01.RES.0000099504.30207.F5 Li, 2002, Activation of NADPH oxidase during progression of cardiac hypertrophy to failure, Hypertension, 40, 477, 10.1161/01.HYP.0000032031.30374.32 Kang, 2006, Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes, Eur J Pharmacol, 535, 212, 10.1016/j.ejphar.2006.01.013 Stull, 2004, Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy, Circ Res, 95, 1005, 10.1161/01.RES.0000148635.73331.c5 Li, 2002, Reactive species mechanisms of cellular hypoxia-reoxygenation injury, Am J Physiol, 282, C227, 10.1152/ajpcell.00112.2001 Nakazono, 1991, Does superoxide underlie the pathogenesis of hypertension?, Proc Nat Acad Sci USA, 88, 10045, 10.1073/pnas.88.22.10045 White, 1994, Superoxide and peroxynitrite in atherosclerosis, Proc Nat Acad Sci USA, 91, 1044, 10.1073/pnas.91.3.1044 Turrens, 2003, Mitochondrial formation of reactive oxygen species, J Physiol, 552, 335, 10.1113/jphysiol.2003.049478 Turrens, 1997, Superoxide production by the mitochondrial respiratory chain, Bioscience Reports, 17, 3, 10.1023/A:1027374931887 Starkov, 2003, Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state, J Neurochem, 86, 1101, 10.1046/j.1471-4159.2003.01908.x Korshunov, 1997, High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria, FEBS Lett, 416, 15, 10.1016/S0014-5793(97)01159-9 Andreyev, 2005, Mitochondrial metabolism of reactive oxygen species, Biochemistry (Mosc), 70, 200, 10.1007/s10541-005-0102-7 Wolin, 2000, Interactions of oxidants with vascular signaling systems, Arter Thromb Vasc Biol, 20, 1430, 10.1161/01.ATV.20.6.1430 Halliwell, 1993, The role of oxygen radicals in human disease, with particular reference to the vascular system, Haemostasis, 23, 118 Sabri, 2003, Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes, Antiox Redox Signal, 5, 731, 10.1089/152308603770380034 Khan, 1995, Reactive oxygen species as cellular messengers, Chem Biol, 2, 437, 10.1016/1074-5521(95)90259-7 Hool, 2000, Hypoxia increases the sensitivity of the L-type Ca(2+) current to beta-adrenergic receptor stimulation via a C2 region-containing protein kinase C isoform, Circ Res, 87, 1164, 10.1161/01.RES.87.12.1164 Hool, 2001, Hypoxia alters the sensitivity of the L-type Ca(2+) channel to alpha-adrenergic receptor stimulation in the presence of beta-adrenergic receptor stimulation, Circ Res, 88, 1036, 10.1161/hh1001.090841 Casey, 2002, Hypoxia causes downregulation of protein and RNA synthesis in noncontracting Mammalian cardiomyocytes, Circ Res, 90, 777, 10.1161/01.RES.0000015592.95986.03 Hool, 2005, Role of NAD(P)H oxidase in the regulation of cardiac L-type Ca2+ channel function during acute hypoxia, Cardiovasc Res, 67, 624, 10.1016/j.cardiores.2005.04.025 Archer, 1999, O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase, Proc Nat Acad Sci USA, 96, 7944, 10.1073/pnas.96.14.7944 Archer, 2000, Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation, Adv Exp Med Biol, 475, 219 O’Kelly, 2001, NADPH oxidase does not account fully for O2-sensing in model airway chemoreceptor cells, Biochem Biophys Res Commun, 283, 1131, 10.1006/bbrc.2001.4919 Hool, 2002, Decreasing cellular hydrogen peroxide with catalase mimics the effects of hypoxia on the sensitivity of the L-type Ca2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes, Circ Res, 91, 601, 10.1161/01.RES.0000035528.00678.D5 Smani, 2002, Reduction of Ca(2+) channel activity by hypoxia in human and porcine coronary myocytes, Cardiovasc Res, 53, 97, 10.1016/S0008-6363(01)00422-9 Fearon, 1997, Hypoxia inhibits the recombinant alpha 1C subunit of the human cardiac L-type Ca2+ channel, J Physiol, 500, 551, 10.1113/jphysiol.1997.sp022041 Fearon, 1999, Modulation of recombinant human cardiac L-type Ca2+ channel alpha1C subunits by redox agents and hypoxia, J Physiol, 514, 629, 10.1111/j.1469-7793.1999.629ad.x Fearon, 2000, Splice variants reveal the region involved in oxygen sensing by recombinant human L-type Ca2+ channels, Circ Res, 87, 537, 10.1161/01.RES.87.7.537 Yamaoka, 2000, Effect of sulfhydryl reagents on the regulatory system of the L-type Ca channel in frog ventricular myocytes, Pflugers Arch, 440, 207, 10.1007/s004249900242 Viola, 2007, A transient exposure to hydrogen peroxide causes an increase in mitochondrial-derived superoxide as a result of sustained alteration in L-type Ca2+ channel function in the absence of apoptosis in ventricular myocytes, Circ Res, 100, 1036, 10.1161/01.RES.0000263010.19273.48 Campbell, 1996, Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols, J Gen Physiol, 108, 277, 10.1085/jgp.108.4.277 Lipton, 1993, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature, 364, 626, 10.1038/364626a0 Gilbert, 1990, Molecular and cellular aspects of thiol-disulfide exchange, Adv Enzymol Relat Areas Mol Biol, 63, 69 Carmeliet, 1999, Cardiac ionic currents and acute ischemia: from channels to arrhythmias, Physiol Rev, 79, 917, 10.1152/physrev.1999.79.3.917 McDonald, 1994, Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells [Review] [1868 refs], Physiol Rev, 74, 365, 10.1152/physrev.1994.74.2.365 Tanskanen, 2005, The role of stochastic and modal gating of cardiac L-type Ca2+ channels on early after-depolarizations, Biophys J, 88, 85, 10.1529/biophysj.104.051508 El-Sherif, 2001, Mechanism of ventricular arrhythmias in the long QT syndrome: on hermeneutics, J Cardiovasc Electrophysiol, 12, 973, 10.1046/j.1540-8167.2001.00973.x Sims, 2008, Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2, Circ Res, 102, e86, 10.1161/CIRCRESAHA.108.173740 January, 1988, A model for early afterdepolarizations: induction with the Ca2+ channel agonist Bay K 8644, Circ Res, 62, 563, 10.1161/01.RES.62.3.563 January, 1989, Early afterdepolarizations: mechanism of induction and block A role for L-type Ca2+ current, Circ Res, 64, 977, 10.1161/01.RES.64.5.977 Marban, 1986, Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle, J Clin Invest, 78, 1185, 10.1172/JCI112701 Yamada, 2008, Contribution of L-type Ca2+ channels to early afterdepolarizations induced by I Kr and I Ks channel suppression in guinea pig ventricular myocytes, J Membr Biol, 222, 151, 10.1007/s00232-008-9113-9 Catterall, 2000, Structure and regulation of voltage-gated Ca2+ channels, Ann Rev Cell Dev Biol, 16, 521, 10.1146/annurev.cellbio.16.1.521 Dzhura, 2000, Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels, Nat Cell Biol, 2, 173, 10.1038/35004052 Volders, 1997, Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes, Cardiovasc Res, 34, 348, 10.1016/S0008-6363(96)00270-2 De Ferrari, 1995, Distinct patterns of calcium transients during early and delayed afterdepolarizations induced by isoproterenol in ventricular myocytes, Circulation, 91, 2510, 10.1161/01.CIR.91.10.2510 Wu, 2002, Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy, Circulation, 106, 1288, 10.1161/01.CIR.0000027583.73268.E7 Mazur, 1999, Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits, Circulation, 100, 2437, 10.1161/01.CIR.100.24.2437 Thomas, 2008, Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in DeltaKPQ Scn5a murine hearts modelling human long QT 3 syndrome, Acta Physiol (Oxf), 192, 505, 10.1111/j.1748-1716.2007.01770.x Gallacher, 2007, In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome, Cardiovasc Res, 76, 247, 10.1016/j.cardiores.2007.06.019 Dorian, 2005, Antiarrhythmic action of beta-blockers: potential mechanisms, J Cardiovasc Pharm Ther, 10, S15, 10.1177/10742484050100i403 Berridge, 2006, Remodelling Ca2+ signalling systems and cardiac hypertrophy, Biochem Soc Trans, 34, 228, 10.1042/BST20060228 Mondry, 1995, Biological adaptation of the myocardium to chronic mechanical overload. Molecular determinants of the autonomic nervous system, Eur Heart J, 16, 64, 10.1093/eurheartj/16.suppl_I.64 Wilkins, 2002, Calcineurin and cardiac hypertrophy: where have we been? Where are we going?, J Physiol, 541, 1, 10.1113/jphysiol.2002.017129 Frey, 2003, Cardiac hypertrophy: the good, the bad, and the ugly, Annu Rev Physiol, 65, 45, 10.1146/annurev.physiol.65.092101.142243 Balke, 1998, Alterations in calcium handling in cardiac hypertrophy and heart failure, Cardiovasc Res, 37, 290, 10.1016/S0008-6363(97)00272-1 Wilkins, 2004, Calcium-calcineurin signaling in the regulation of cardiac hypertrophy, Biochem Biophys Res Commun, 322, 1178, 10.1016/j.bbrc.2004.07.121 van Empel, 2004, Myocyte hypertrophy and apoptosis: a balancing act, Cardiovasc Res, 63, 487, 10.1016/j.cardiores.2004.02.013 Ruwhof, 2000, Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways, Cardiovasc Res, 47, 23, 10.1016/S0008-6363(00)00076-6 Dorn, 2005, Protein kinase cascades in the regulation of cardiac hypertrophy, J Clin Invest, 115, 527, 10.1172/JCI24178 Molkentin, 1998, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy, Cell, 93, 215, 10.1016/S0092-8674(00)81573-1 McKinsey, 2007, Derepression of pathological cardiac genes by members of the CaM kinase superfamily, Cardiovasc Res, 73, 667, 10.1016/j.cardiores.2006.11.036 Dolmetsch, 1997, Differential activation of transcription factors induced by Ca2+ response amplitude and duration, Nature, 386, 855, 10.1038/386855a0 Sucharov, 2006, A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction, Am J Physiol, 291, H1299 Zobel, 2007, Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy, Cardiology, 107, 281, 10.1159/000099063 Bodi, 2003, Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: complex nature of K+ current changes and action potential duration, J Am Coll Cardiol, 41, 1611, 10.1016/S0735-1097(03)00244-4 Zou, 2002, Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats, Hypertens Res, 25, 117, 10.1291/hypres.25.117 Murata, 2004, Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart, Circ Res, 95, 398, 10.1161/01.RES.0000138449.85324.c5 Cingolani, 2007, Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy, Circ Res, 101, 166, 10.1161/CIRCRESAHA.107.155721 Ganesan, 2005, Reverse engineering the L-type Ca2+ channel alpha1c subunit in adult cardiac myocytes using novel adenoviral vectors, Biochem Biophys Res Commun, 329, 749, 10.1016/j.bbrc.2005.02.015